Boston Immune Technologies and Therapeutics, Inc. (BITT), a biotechnology company in the clinical stage, has announced that its Investigational New Drug application (IND) for BITT2101 (anti-TNFR2), a novel tumor necrosis factor superfamily receptor (TNFSR) antagonist antibody

CervoMed Inc. (formerly Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments for degenerative brain diseases, has successfully completed its previously announced merger with EIP Pharma Inc.

Tigermed (300347.SZ/3347.HK), a prominent global Contract Research Organization (CRO) offering comprehensive research and development solutions for the biopharmaceutical and medical device sectors, has officially inaugurated its International Headquarters in Hong Kong.

We are pleased to announce a fresh collaboration with Asahi Kasei Pharma Corporation aimed at producing clinical drug substance for antibody-based therapies.

Impilo Therapeutics, Inc. (referred to as "Impilo"), a privately-owned enterprise specializing in drug discovery and development, has officially launched its operations with a core mission to facilitate the effective utilization of nucleic acid-based medicines for the treatment of solid tumor cancers.

Nexus Pharmaceuticals has announced its receipt of approval from the U.S. Food and Drug Administration (FDA) for Potassium Chloride for Injection Concentrate, USP in 10mL and 20mL Single-Dose Vials.

Asieris Pharmaceuticals (688176) is a prominent global biopharmaceutical firm specializing in the research, development, and commercialization of novel drugs targeting genitourinary tumors and related ailments.

Antengene Corporation Limited (SEHK: 6996.HK), a prominent global biopharmaceutical company focused on innovative therapies in hematology and oncology

Rising Pharmaceuticals, a subsidiary of Rising Pharma Holdings Inc., has announced the approval, launch, and immediate availability of Edetate calcium disodium injection, addressing a critical shortage of this vital therapy in the United States.

Brenntag, a prominent global player in the distribution of chemicals and ingredients, has announced a strategic collaboration with audit provider Qualifyze.